E-LIB Suche - Ergebnisse für: Carton, Charlotte

1

Platform trial design for neurofibromatosis type 1, NF2-rel..:

Dhaenens, Britt A E ; Heimann, Günter ; Bakker, Annette...
Neuro-Oncology Practice. 11 (2024) 4 - p. 395-403 , 2024

Link: https://doi.org/10.1093/..

2

ERN GENTURIS tumour surveillance guidelines for individuals..:

Carton, Charlotte ; Evans, D. Gareth ; Blanco, Ignacio...
eClinicalMedicine. 56 (2023) - p. 101818 , 2023

Link: https://doi.org/10.1016/..

3

Lessons learned from drug trials in neurofibromatosis: A sy..:

Dhaenens, Britt A.E. ; Ferner, Rosalie E. ; Evans, D. Gareth...
European Journal of Medical Genetics. 64 (2021) 9 - p. 104281 , 2021

Link: https://doi.org/10.1016/..

4

Incidence, prevalence and long-term progression of Goh algo..:

Vandecasteele, Els ; Melsens, Karin ; Vanhaecke, Amber...
Seminars in Arthritis and Rheumatism. 51 (2021) 5 - p. 969-976 , 2021

Link: https://doi.org/10.1016/..

5

Ocular involvement in systemic sclerosis: A systematic lite..:

Kreps, Elke O. ; Carton, Charlotte ; Cutolo, Maurizio...
Seminars in Arthritis and Rheumatism. 49 (2019) 1 - p. 119-125 , 2019

Link: https://doi.org/10.1016/..

6

ERN GENTURIS tumour surveillance guidelines for individuals..:

Carton, Charlotte ; Evans, D. Gareth ; Blanco, Ignacio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845795/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Incidence, prevalence and long-term progression of Goh algo..:

Vandecasteele, Els ; Melsens, Karin ; Vanhaecke, Amber...
boreal:261504. , 2021

Link: http://hdl.handle.net/20..

8

Lessons learned from drug trials in neurofibromatosis:A sys..:

Dhaenens, Britt A.E ; Ferner, Rosalie E ; Evans, D. Gareth...
Dhaenens , B A E , Ferner , R E , Evans , D G , Heimann , G , Potratz , C , van de Ketterij , E , Kaindl , A M , Hissink , G , Carton , C , Bakker , A , Nievo , M , Legius , E & Oostenbrink , R 2021 , ' Lessons learned from drug trials in neurofibromatosis : A systematic review ' , European Journal of Medical Genetics , vol. 64 , no. 9 , 104281 . https://doi.org/10.1016/j.ejmg.2021.104281. , 2021

Link: https://pure.eur.nl/en/p..

9

Incidence, prevalence and long-term progression of Goh algo..:

Vandecasteele, Els ; Melsens, Karin ; Vanhaecke, Amber...
boreal:261504. , 2021

Link: http://hdl.handle.net/20..

10

Fast track algorithm: How to differentiate a "scleroderma p..:

Smitha Vanessa ; Vanhaecke Amber ; Herrick Ariane L...
info:eu-repo/semantics/altIdentifier/pmid/31520797. , 2019

Link: http://hdl.handle.net/24..

11

Current state-of-the-art and gaps in platform trials: 10 th..:

Franz Koenig ; Cécile Spiertz ; Daniel Millar...
http://www.sciencedirect.com/science/article/pii/S2589537023005618. , 2024

Link: https://doi.org/10.1016/..

12

ERN GENTURIS tumour surveillance guidelines for individuals..:

Charlotte Carton ; D. Gareth Evans ; Ignacio Blanco...
http://www.sciencedirect.com/science/article/pii/S2589537022005478. , 2023

Link: https://doi.org/10.1016/..

13

Lessons learned from drug trials in neurofibromatosis:

B.A.E. (Britt) Dhaenens ; Rosalie E. Ferner ; D. Gareth Evans...
http://repub.eur.nl/pub/135907. , 2021

Link: http://repub.eur.nl/pub/..

14

Fast Track Algorithm: How To Differentiate A "Scleroderma P..:

Smith, Vanessa ; Vanhaecke, Amber ; Herrick, Ariane L...
10.1016/j.autrev.2019.102394. , 2019

Link: http://hdl.handle.net/11..

15

Factors associated with the use of benzodiazepine and opioi..:

Thomas, Charlotte ; Dondaine, Thibaut ; Caron, Clément...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..